Septic Transfusion Reactions: Lessons from the Headlines and Hemovigilance

Septic reactions from apheresis platelet transfusion are a leading cause of morbidity and mortality, but there are opportunities to increase awareness, recognition and reporting that could improve safety for patients.

TARGET AUDIENCE/PRE-REQUISITES
Technologists, Technicians, Laboratory Managers
There are no participant prerequisites for this activity.

SUCCESSSM CREDITS: 1.0 CEU

Enter Course

LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:

  1. Review cases of septic transfusion reactions after platelet transfusion reported to the Red Cross or in recent headlines.
  2. Describe the Red Cross hemovigilance data on bacterial contamination of apheresis platelets and the risk of septic transfusion reactions.
  3. Discuss how hospitals can improve transfusion safety for patients.

LEARNING TASKS
To receive CEU credit for this activity, participants must:

  1. Acknowledge their review of activity prerequisites, objectives, disclosures, methods of physician participation and statements.
  2. Review the presentation "Septic Transfusion Reactions: Lessons from the headlines and Hemovigilance" or review the slides and accompanying notes available as a printable Adobe ReaderĀ® file.
  3. Take the online Post-Test.
  4. Complete the online Activity Evaluation.
  5. Print the certificate awarding 1.0 SUCCESS CEU.

FACULTY
Anne Eder, MD PhD
Associate Deputy Director for Medical Issues and Policy Development, Food and Drug Administration (FDA)
Rockville, MD


LEARNING REFERENCES

Listed in the presentation.

DISCLOSURES
Activity faculty and planners have indicated that they have no relevant financial relationships with commercial interests to disclose. No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only and not to endorse off-label use. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

PASSING REQUIREMENTS
If you correctly answer 70% or more of the post-test items you may claim credit.Ā 

RELEASE DATE: 12/07/2015

EXPIRATION DATE: 12/06/2017

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour(s)

This activity has been designed for general, specialty, and subspecialty physicians who prescribe blood products, care for blood donors or have related interests. There are no participant prerequisites for this activity.

CEU CREDITS:
1.0 SUCCESS CEU
Last modified: Friday, February 10, 2017, 11:58 AM